Sign in to view content

Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes

Jeffrey G. Gross, MD, FASRS

Video
Published 2018

Related

Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial
Philip J. Ferrone, MD, FASRS
Annual Meeting Talks
2019
Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results
Peter J. Kertes, MD, FRCS(C)
Updates from the Field
2018
DRCR.net Anti-VEGF Comparative Effectiveness Trial for Diabetic Macular Edema
Neil M. Bressler, MD
Member Podcasts

Category: Diabetic Retinopathy

See more